Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $16.2500 (-3.68%) ($16.1100 - $16.9400) on Fri. Apr. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.83% (three month average) | RSI | 57 | Latest Price | $16.2500(-3.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.4% a day on average for past five trading days. | Weekly Trend | HALO advances 6.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(52%) IWO(52%) IWM(47%) ARKG(45%) IWC(45%) | Factors Impacting HALO price | HALO will decline at least -1.915% in a week (0% probabilities). VIXM(-31%) VXX(-15%) UUP(-14%) TLT(-4%) USO(4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.915% (StdDev 3.83%) | Hourly BBV | 0 () | Intraday Trend | -3.2% | | | |
|
Resistance Level | $16.79 | 5 Day Moving Average | $17.12(-5.08%) | 10 Day Moving Average | $17.13(-5.14%) | 20 Day Moving Average | $16.79(-3.22%) | To recent high | -25.6% | To recent low | 16.9% | Market Cap | $2.221b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |